Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02039115 · ClinicalTrials.gov registry record · Phase 4
Reduction in Symptomatic Esophageal Stricture Formation
A Phase 4 study, sponsored by AdventHealth.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT02039115 is a Phase 4 study that was terminated before completion, run by AdventHealth. The registered enrollment target is 3 participants.
The verdict
NCT02039115, a Phase 4 study, was terminated before completion, sponsored by AdventHealth.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
Complete endoscopic resection of early neoplastic Barrett's Esophagus (BE) is a curative procedure. However, a significant proportion of patients develop symptomatic esophageal strictures following Complete Barrett's Eradication (CBE), and this limits the technique, particularly for circumferential and longer segment disease. Oral steroid therapy may reduce stricture formation; thereby allowing CBE to be performed with minimal associated morbidity.
Interventions
- DRUG placebo
- DRUG prednisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02039115
The ClinicalTrials.gov registry entry for NCT02039115 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02039115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02039115 about?
NCT02039115 is a clinical study titled "Reduction in Symptomatic Esophageal Stricture Formation". Complete endoscopic resection of early neoplastic Barrett's Esophagus (BE) is a curative procedure. However, a significant proportion of patients develop symptomatic esophageal strictures following Complete Barrett's Eradication (CBE), and this limits the technique, particularly for circumferential ...
What is the current status of trial NCT02039115?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2014-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02039115?
The interventions under investigation include: placebo (DRUG), prednisone (DRUG).
Who is sponsoring clinical trial NCT02039115?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.